Based on this, we essentially addressed the question of plausible modulators regulating two key pillars of RA pathogenesis i.e. inflammation and bone degradation and accordingly examined the IL-21/23 axis and its downstream signaling pathway in RA CD4+ T cell population. This evidence concerns the gene CD4 and rheumatoid arthritis.